Medically reviewed by Renita White, MD Key Takeaways Ovarian cancer treatment often includes surgery and chemotherapy, but ...

Each cell in our body experiences up to tens of thousands of DNA-damaging events per day, primarily from routine cellular maintenance or exposure to toxins in our environment. Despite the high ...

Data analysis reveals a stable, cross-cohort female cancer mortality excess at ages 35-60, contrasting with female advantages in cardiovascular and external-cause mortality. Breast cancer drives the ...

A breast cancer drug could provide new options for people suffering from treatment-resistant uterine cancer, according to new Yale School of Medicine research. Uterine cancer is the deadliest cancer ...

About The Study: In this population-level cohort study of 20 low-mortality countries, females ages 35 to 60 experienced disadvantage in cancer mortality compared with males—a consistent pattern ...

High BMI is a significant modifiable risk factor for ovarian and uterine cancers, with disparities across sociodemographic index levels. The Global Burden of Diseases Study 2021 analyzed trends in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Women in low-mortality countries live 4 to 8 years ...

Medically reviewed by Andrea L. Braden, MD Key Takeaways The female reproductive system includes organs that produce hormones ...

“My whole focus is using my background in drug discovery to target proteins we think are involved for female reproductive cancers,” says Sarah Hengel. Here, a photomicrograph of a uterine biopsy ...